期刊文献+

糖尿病合并21-三体综合征及毒性弥漫性甲状腺肿1例报告 被引量:1

Diabetes combined with Down's disease and Grave's disease:A case report
原文传递
导出
摘要 患者因"多饮、多尿2年,咳嗽、呕吐、腹痛1d"入院。鼻梁塌陷,眼距增宽,常见张口伸舌状。甲状腺Ⅱ度大,质软。血糖47.77mmol/L,第三代促甲状腺素(TSH)0.06μIU/ml,促甲状腺受体抗体(TRAB)15U/L,染色体核型检查:46,XX,-14,+t(14q21q)(G带核型)。诊断糖尿病合并21-三体综合征及毒性弥漫性甲状腺肿。 [Summary] A patient was admitted to the hospital because of polydipsia and polyuria for two years,cough,vomiting,and abdominal pain for one day.The patient had ocular hypertelorism and goiter.Blood glucose was 47.77 mmol/L,the third generation of thyroid stimulating hormone (TSH) was 0.06 μIU/ml,thyrotropin receptor antibody (TRAB) was 15 U/L,chromosome examination was 46,XX,-14,--t (14q21q) (G banding).The patient was diagnosed as diabetes associated with Down' s disease and Grave's disease.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第12期1138-1139,共2页 Chinese Journal of Diabetes
关键词 糖尿病 21-三体综合征 毒性弥漫性甲状腺肿 Diabetes Down's disease Grave's disease
  • 相关文献

参考文献4

二级参考文献15

  • 1Hirata Y.Insulin autoimmune syndrome.Nippon Rinsho,1973,31:2227-2231.
  • 2Hirata Y.Methimazole and insulin autoimmune syndrome with hypoglycaemia.Lancet,1983,2:1037-1038.
  • 3Uchigata Y,Eguchi Y,Takayama-Hasumi S,et al.Insulin autoimmune syndrome (Hirata disease):clinical features and epidemiology in Japan.Diabetes Res Clin Pract,1994,22:89-94.
  • 4Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab, 2006, 91:225-227.
  • 5Isidro ML, Penin MA, Nemifia R,et al. Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine, 2007,32:79-82.
  • 6Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharma cokinet, 1996,30 : 359-371.
  • 7Scheen AJ. Drug interactions of clinical importance with antihyperglycaemic agents: an update. Drug Saf, 2005,28 : 601 631.
  • 8Velija Asimi Z. C-reactive protein in obese PCOS women and the effect of metformin therapy. Bosn J Basic Med Sei, 2007, 7: 90-93.
  • 9Dittmar M, Heintz A, Hardt J, et al. Metabolic and psychosocial effects of minimal invasive gastric banding for morbid obesity. Metabolism, 2003,52 : 1551-1557.
  • 10Oleandri SE, Maccario M, Rossetto R, et al. Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. J Endocrinol Invest, 1999, 22: 134-140.

共引文献48

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部